LW231

· Shanghai Longwood Biopharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LW231, covering 2024-10-15 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of LW231 in Participants With Chronic Hepatitis B [Phase 1, Phase 2]